- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
In the Literature: microRNA Biomarkers For Early Detection of Childhood Cancers
Research to be presented this week at the National Cancer Research Institute Cancer Conference has identified the expression of specific serum microRNAs in pediatric solid tumors, which could prove useful for early diagnosis.
Newly-identified cancer cell fingerprints in the blood could one day help doctors diagnose a range of children's cancers faster and more accurately, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference next week.
The researchers, from the University of Cambridge and Addenbrooke's Hospital in Cambridge, found unique molecular fingerprints for 11 types of children's tumours, which could be used to develop blood tests to diagnose these cancers.
This may eventually lead to a quicker, more accurate way to diagnose tumours, and could also reduce the need for children to undergo surgery to get a diagnosis one day.
The research was funded by Sparks, the children's medical research charity, and Cancer Research UK.
Link to the report on MedicalXpress: http://bit.ly/1tuDIES
Link to the abstract: http://bit.ly/10jNAHz
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
